Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Some VCs Have Miles To Go While Others Have Burned What's In The Tank

This article was originally published in The Pink Sheet Daily

Executive Summary

A handful of life sciences venture capital funds, but not all of them, are thriving in an environment of cautious limited partner investing.
Advertisement

Related Content

Unnamed Lilly "Mirror Fund" Acquires First Two Compounds
Biotech Ventures Forth: Third Rock Rolls Out $426M Fund, Relypsa Reloads
Biotech Ventures Forth: Third Rock Rolls Out $426M Fund, Relypsa Reloads

Topics

Advertisement
UsernamePublicRestriction

Register

PS072682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel